Profile data is unavailable for this security.
About the company
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
- Revenue in USD (TTM)21.92bn
- Net income in USD1.76bn
- Incorporated1906
- Employees72.00k
- LocationBecton Dickinson and CoOne Becton DriveFRANKLIN LAKES 07417-1880United StatesUSA
- Phone+1 (201) 847-6800
- Websitehttps://www.bd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DexCom Inc | 4.66bn | 836.30m | 28.13bn | 11.00k | 35.38 | 10.24 | 25.85 | 6.03 | 2.07 | 2.07 | 11.50 | 7.14 | 0.727 | 3.02 | 4.20 | 423,818.20 | 13.04 | 8.85 | 21.58 | 12.58 | 62.09 | 63.92 | 17.94 | 14.21 | 1.59 | -- | 0.3204 | -- | 15.60 | 19.33 | 45.14 | 8.75 | 12.81 | -- |
| Veeva Systems Inc | 3.08bn | 860.33m | 30.56bn | 7.29k | 36.16 | 4.34 | 33.96 | 9.92 | 5.14 | 5.14 | 18.41 | 42.84 | 0.4234 | -- | 9.15 | 422,472.40 | 11.83 | 11.33 | 13.50 | 14.35 | 75.67 | 72.60 | 27.93 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Waters Corp | 3.17bn | 642.63m | 30.62bn | 7.90k | 29.01 | 7.26 | 36.04 | 9.67 | 10.76 | 10.76 | 53.01 | 43.01 | 0.6574 | 2.46 | 4.05 | 400,669.10 | 13.35 | 17.03 | 16.91 | 21.51 | 59.28 | 59.00 | 20.30 | 22.40 | 1.27 | 15.81 | 0.3546 | 0.00 | 6.99 | 6.00 | 0.7518 | 4.26 | -8.14 | -- |
| Agilent Technologies Inc | 7.07bn | 1.29bn | 33.65bn | 18.10k | 26.28 | 4.87 | 21.39 | 4.76 | 4.53 | 4.53 | 24.81 | 24.44 | 0.5714 | 3.26 | 4.96 | 390,331.50 | 10.43 | 11.44 | 12.51 | 13.67 | 52.53 | 53.25 | 18.26 | 18.82 | 1.59 | 19.12 | 0.3268 | 20.76 | 6.73 | 5.41 | 1.09 | 12.63 | 27.88 | 7.10 |
| GE HealthCare Technologies Inc | 20.63bn | 2.09bn | 35.61bn | 54.00k | 17.16 | 3.43 | 13.03 | 1.73 | 4.55 | 4.55 | 45.03 | 22.77 | 0.5893 | 5.93 | 4.31 | 381,944.40 | 6.15 | 6.70 | 8.46 | 9.25 | 39.98 | 40.44 | 10.44 | 10.49 | 1.13 | 9.97 | 0.4866 | 1.85 | 4.84 | 3.74 | 4.57 | 0.7558 | 13.23 | -- |
| Resmed Inc | 5.40bn | 1.49bn | 37.63bn | 10.60k | 25.53 | 5.95 | 22.25 | 6.97 | 10.12 | 10.12 | 36.75 | 43.39 | 0.6901 | 2.34 | 5.53 | 509,256.50 | 19.00 | 15.33 | 21.94 | 17.76 | 60.85 | 57.29 | 27.53 | 21.96 | 2.32 | -- | 0.095 | 28.94 | 9.84 | 11.72 | 37.20 | 17.64 | -1.02 | 1.69 |
| Edwards Lifesciences Corp | 6.07bn | 1.06bn | 49.53bn | 16.00k | 47.21 | 4.79 | 40.85 | 8.16 | 1.81 | 1.83 | 10.36 | 17.80 | 0.4536 | 1.21 | 9.57 | 379,225.00 | 7.89 | 13.08 | 9.04 | 14.96 | 78.01 | 79.39 | 17.40 | 24.79 | 3.09 | -- | 0.0547 | 0.00 | 11.55 | 6.70 | -24.33 | 5.18 | -8.57 | -- |
| Becton Dickinson and Co | 21.92bn | 1.76bn | 49.60bn | 72.00k | 28.48 | 1.96 | 11.74 | 2.26 | 6.12 | 6.12 | 76.34 | 88.79 | 0.4004 | 2.96 | 8.52 | 304,500.00 | 3.21 | 3.00 | 3.78 | 3.48 | 46.42 | 45.58 | 8.01 | 8.20 | 0.5826 | 6.68 | 0.4359 | 66.89 | 8.24 | 6.32 | -1.58 | 46.93 | -0.2352 | 5.65 |
| IDEXX Laboratories Inc | 4.30bn | 1.06bn | 50.60bn | 11.00k | 48.59 | 31.56 | 42.01 | 11.76 | 13.08 | 13.08 | 53.12 | 20.14 | 1.30 | 4.33 | 7.40 | 391,245.60 | 31.89 | 28.96 | 47.86 | 43.58 | 61.80 | 60.30 | 24.62 | 22.86 | 0.9019 | 37.97 | 0.3456 | 0.00 | 10.42 | 9.72 | 19.33 | 12.74 | 5.08 | -- |
| Medline Inc | 28.43bn | 1.16bn | 58.31bn | 45.00k | 50.32 | 5.43 | 28.84 | 2.05 | 0.8822 | 0.8822 | 21.64 | 8.17 | -- | -- | -- | 631,822.30 | -- | -- | -- | -- | 26.44 | -- | 4.07 | -- | 2.37 | 2.59 | 0.3944 | -- | 11.47 | -- | -3.42 | -- | -- | -- |
| Cencora Inc | 325.78bn | 1.63bn | 72.26bn | 51.00k | 44.68 | 37.86 | 26.85 | 0.2218 | 8.31 | 8.31 | 1,671.64 | 9.81 | 4.42 | 14.08 | 12.21 | 6,387,800.00 | 2.23 | 2.64 | 9.81 | 11.63 | 3.63 | 3.38 | 0.5035 | 0.6038 | 0.5086 | 11.82 | 0.7908 | 24.98 | 9.31 | 11.09 | 2.99 | -- | 12.56 | 5.79 |
Data as of Mar 04 2026. Currency figures normalised to Becton Dickinson and Co's reporting currency: US Dollar USD
40.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 33.76m | 11.85% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 14.92m | 5.24% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 14.38m | 5.05% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 13.99m | 4.91% |
| First Eagle Investment Management LLCas of 31 Dec 2025 | 11.65m | 4.09% |
| Geode Capital Management LLCas of 31 Dec 2025 | 6.89m | 2.42% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 5.60m | 1.97% |
| Wellington Management Co. LLPas of 31 Dec 2025 | 5.05m | 1.77% |
| Putnam Investment Management LLCas of 31 Dec 2025 | 4.09m | 1.44% |
| ClearBridge Investments LLCas of 31 Dec 2025 | 4.09m | 1.44% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
